ABEO
Abeona Therapeutics Inc
Price:  
6.24 
USD
Volume:  
946,742.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ABEO WACC - Weighted Average Cost of Capital

The WACC of Abeona Therapeutics Inc (ABEO) is 10.1%.

The Cost of Equity of Abeona Therapeutics Inc (ABEO) is 10.55%.
The Cost of Debt of Abeona Therapeutics Inc (ABEO) is 5.00%.

Range Selected
Cost of equity 8.70% - 12.40% 10.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.4% - 11.9% 10.1%
WACC

ABEO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.05 1.34
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.70% 12.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.06 0.06
Cost of debt 5.00% 5.00%
After-tax WACC 8.4% 11.9%
Selected WACC 10.1%

ABEO's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ABEO:

cost_of_equity (10.55%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (1.05) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.